Literature DB >> 22421698

Incidence, prevalence, and epidemiology of herpes simplex virus-2 in HIV-1-positive and HIV-1-negative adolescents.

Staci L Sudenga1, Mirjam-Colette Kempf, Gerald McGwin, Craig M Wilson, Edward W Hook, Sadeep Shrestha.   

Abstract

BACKGROUND: Several studies have assessed risk factors associated with herpes simplex virus-2 (HSV-2) prevalence in adults; however, few have focused on HSV-2 incidence, particularly in adolescents. The objective of this study was to determine HSV-2 prevalence and incidence and associated risk factors in a HIV-1-positive and at risk HIV-1-negative adolescent population.
METHODS: Sera were tested for HSV-2 antibodies in 518 adolescents in the Reaching for Excellence in Adolescent Care and Health cohort at baseline and again at the final follow-up visit. Prevalence at baseline and incidence (per person years) of HSV-2 infection were calculated. Furthermore, among HIV-1-positive individuals, a subgroup analysis was performed to assess risk factors for HSV-2 infection. Conditional logistic regression was used to estimate odds ratios and P values for associations between CD4+ T-cell (CD4+) count, HIV-1 viral load (VL), and HSV-2 acquisition, adjusting for antiretroviral therapy use, other sexually transmitted infections, gender, race, and number of sexual partners.
RESULTS: At baseline, 179 (35%) subjects were HSV-2 positive, with an additional 47 (16%) new cases being identified during a median follow-up time of 1.95 years and an incidence rate of 7.35 cases per 100 person years. Several risk factors were associated with HSV-2 prevalence (being female, non-Hispanic, uncertainty of sexual preference, and HIV-1 positive) and incidence (using drugs, alcohol, and number of new sexual partners). Among HIV-1 positives, an increase in CD4+ count by 50 cell/mm(3) (odds ratio, 1.17; 95% CI, 1.04-1.31, P = 0.008) was associated with HSV-2 acquisition.
CONCLUSIONS: The high prevalence and incidence of HSV-2 infection among adolescents, compared with the general population at this age group suggests a critical need for screening and preventive programs among this targeted group.

Entities:  

Mesh:

Year:  2012        PMID: 22421698      PMCID: PMC3306602          DOI: 10.1097/OLQ.0b013e318244a90f

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN: 0148-5717            Impact factor:   2.830


  28 in total

1.  The relationship between condom use and herpes simplex virus acquisition.

Authors:  Anna Wald; Andria G M Langenberg; Elizabeth Krantz; John M Douglas; H Hunter Handsfield; Richard P DiCarlo; Adaora A Adimora; Allen E Izu; Rhoda Ashley Morrow; Lawrence Corey
Journal:  Ann Intern Med       Date:  2005-11-15       Impact factor: 25.391

2.  Trends in herpes simplex virus type 1 and type 2 seroprevalence in the United States.

Authors:  Fujie Xu; Maya R Sternberg; Benny J Kottiri; Geraldine M McQuillan; Francis K Lee; Andre J Nahmias; Stuart M Berman; Lauri E Markowitz
Journal:  JAMA       Date:  2006-08-23       Impact factor: 56.272

3.  Herpes simplex virus type 2 infection increases HIV incidence: a prospective study in rural Tanzania.

Authors:  María del Mar Pujades Rodríguez; Angela Obasi; Frank Mosha; Jim Todd; David Brown; John Changalucha; David Mabey; David Ross; Heiner Grosskurth; Richard Hayes
Journal:  AIDS       Date:  2002-02-15       Impact factor: 4.177

4.  Seroprevalence of herpes simplex virus type 2 among persons aged 14-49 years--United States, 2005-2008.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2010-04-23       Impact factor: 17.586

5.  New insights on interactions between HIV-1 and HSV-2.

Authors:  Sinéad Delany-Moretlwe; Jairam R Lingappa; Connie Celum
Journal:  Curr Infect Dis Rep       Date:  2009-03       Impact factor: 3.725

6.  Effect of highly active antiretroviral therapy on incidence of early syphilis in HIV-infected patients.

Authors:  Wan Beom Park; Hee-Chang Jang; Sung-Han Kim; Hong Bin Kim; Nam Joong Kim; Myoung-Don Oh; Kang Won Choe
Journal:  Sex Transm Dis       Date:  2008-03       Impact factor: 2.830

Review 7.  Genital herpes.

Authors:  Rachna Gupta; Terri Warren; Anna Wald
Journal:  Lancet       Date:  2007-12-22       Impact factor: 79.321

8.  Risk factors for incident herpes simplex type 2 virus infection among women attending a sexually transmitted disease clinic.

Authors:  Maria F Gallo; Lee Warner; Maurizio Macaluso; Katherine M Stone; Ilene Brill; Michael E Fleenor; Edward W Hook; Harland D Austin; Francis K Lee; André J Nahmias
Journal:  Sex Transm Dis       Date:  2008-07       Impact factor: 2.830

9.  Transmission probabilities of HIV and herpes simplex virus type 2, effect of male circumcision and interaction: a longitudinal study in a township of South Africa.

Authors:  Severin-Guy Mahiane; Camille Legeai; Dirk Taljaard; Aurelien Latouche; Adrian Puren; Aurelie Peillon; Jean Bretagnolle; Pascale Lissouba; Eugene-Patrice Ndong Nguema; Elisabeth Gassiat; Bertran Auvert
Journal:  AIDS       Date:  2009-01-28       Impact factor: 4.177

10.  Antiretroviral therapy and sexual behavior in Uganda: a cohort study.

Authors:  Leigh Anne Shafer; Rebecca N Nsubuga; Richard White; Billy N Mayanja; Ruth Chapman; Katie O'brien; Lieve Van der Paal; Heiner Grosskurth; Dermot Maher
Journal:  AIDS       Date:  2011-03-13       Impact factor: 4.177

View more
  9 in total

1.  High Rates of Herpes Simplex Virus Type 2 Infection in Homeless Women: Informing Public Health Strategies.

Authors:  J Daniel Kelly; Jennifer Cohen; Barbara Grimes; Susan S Philip; Sheri D Weiser; Elise D Riley
Journal:  J Womens Health (Larchmt)       Date:  2016-05-31       Impact factor: 2.681

2.  Associations of HLA-A, HLA-B and HLA-C alleles frequency with prevalence of herpes simplex virus infections and diseases across global populations: implication for the development of an universal CD8+ T-cell epitope-based vaccine.

Authors:  Sarah Samandary; Hédia Kridane-Miledi; Jacqueline S Sandoval; Zareen Choudhury; Francina Langa-Vives; Doran Spencer; Aziz A Chentoufi; François A Lemonnier; Lbachir BenMohamed
Journal:  Hum Immunol       Date:  2014-05-04       Impact factor: 2.850

3.  Sexually transmitted infections and immune activation among HIV-infected but virally suppressed youth on antiretroviral therapy.

Authors:  Tanya L Kowalczyk Mullins; Su X Li; James Bethel; Maureen M Goodenow; Stephanie Hudey; John W Sleasman
Journal:  J Clin Virol       Date:  2018-02-07       Impact factor: 3.168

Review 4.  The effect of sexually transmitted co-infections on HIV viral load amongst individuals on antiretroviral therapy: a systematic review and meta-analysis.

Authors:  David Champredon; Steven E Bellan; Wim Delva; Spencer Hunt; Chyun-Fung Shi; Marek Smieja; Jonathan Dushoff
Journal:  BMC Infect Dis       Date:  2015-06-30       Impact factor: 3.090

Review 5.  Herpes Simplex Virus Evasion of Early Host Antiviral Responses.

Authors:  Eduardo I Tognarelli; Tomás F Palomino; Nicolás Corrales; Susan M Bueno; Alexis M Kalergis; Pablo A González
Journal:  Front Cell Infect Microbiol       Date:  2019-04-30       Impact factor: 5.293

6.  Seroprevalence and characterisation of herpes simplex virus from human immunodeficiency virus in samples collected from two provinces in South Africa: a retrospective study.

Authors:  Oluwafemi Samuel Obisesan; Nomathamsanqa Patricia Sithebe; Hazel Tumelo Mufhandu
Journal:  F1000Res       Date:  2021-02-11

Review 7.  Disease progression mediated by egr-1 associated signaling in response to oxidative stress.

Authors:  Judith-Irina Pagel; Elisabeth Deindl
Journal:  Int J Mol Sci       Date:  2012-10-12       Impact factor: 5.923

8.  Seroprevalence of HSV-1 and 2 in HIV-infected males with and without GUD: Study from a tertiary care setting of India.

Authors:  Arshi Munawwar; Somesh Gupta; Surendra Kumar Sharma; Sarman Singh
Journal:  J Lab Physicians       Date:  2018 Jul-Sep

9.  Evaluation of a nanophosphor lateral-flow assay for self-testing for herpes simplex virus type 2 seropositivity.

Authors:  Heather J Goux; Balakrishnan Raja; Katerina Kourentzi; João R C Trabuco; Binh V Vu; Andrew S Paterson; Alexander Kirkpatrick; Blane Townsend; Miles Lee; Van Thi Thanh Truong; Claudia Pedroza; Richard C Willson
Journal:  PLoS One       Date:  2019-12-10       Impact factor: 3.752

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.